DERM Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane

03

Prezzo $6.61

P/E (TTM) -30.0

EPS (TTM) $-0.22

Ricavi (TTM) $68M

ROE (TTM) -23.8%

D/E Debito/Patrimonio (MRQ) 0.8

Intervallo 52 sett. $4–$9

DERM Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione

04

intervallo

barre

La granularità delle barre si adatta al periodo selezionato — passa il mouse sul grafico per vedere apertura/massimo/minimo/chiusura di una barra.

Performance decennale Andamento di ricavi, utile netto, margini e EPS

06

Ricavi$62M

2020-12-31 → 2025-12-31

EPS$-0.47

2020-12-31 → 2025-12-31

Flusso di cassa libero·

2022-12-31 → 2024-12-31

Margine netto-9.0%

2021-12-31 → 2025-12-31

Valutazione e Rapporti 07–12

Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?

Metrica	Tendenza 5 anni	DERM	media 5 anni	Mediana dei peer	Verdetto
P/E (TTM)		-30.0media 5 anni ≈-10.3	≈-10.3	·	·

La mediana dei peer viene calcolata su base standardizzata per metrica e potrebbe non corrispondere sempre alla base TTM/MRQ mostrata per questo titolo.

Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC

Metrica	DERM	media 5 anni	Mediana dei peer	Verdetto
Margine Operativo (TTM)	-4.4%media 5 anni ≈-26.6%	≈-26.6%	-590.8%	Di prim'ordine
EBITDA Margin (Margine EBITDA)	-13.2%media 5 anni ≈-26.6%	≈-26.6%	-294.2%	Di prim'ordine
Margine ante imposte (TTM)	-8.9%media 5 anni ≈-31.2%	≈-31.2%	36.2%	Debole
Margine di Profitto Netto (TTM)	-9.0%media 5 anni ≈-31.9%	≈-31.9%	14.4%	Sotto la media
ROA (TTM)	-6.8%media 5 anni ≈-24.8%	≈-24.8%	-13.1%	In linea
ROE (TTM)	-23.8%media 5 anni ≈-117.4%	≈-117.4%	-33.5%	Debole
ROIC	-14.4%media 5 anni ≈-42.5%	≈-42.5%	-14.4%	In linea

Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio

Metrica	DERM	media 5 anni	Mediana dei peer	Verdetto
Debito / Patrimonio Netto (MRQ)	0.8media 5 anni ≈1.0	≈1.0	1.1	Basso indebitamento
Rapporto corrente (MRQ)	1.6media 5 anni ≈1.5	≈1.5	4.7	Bassa liquidità
Quick Ratio	1.4media 5 anni ≈1.1	≈1.1	1.5	Bassa liquidità
Debito a lungo termine / Patrimonio netto (MRQ)	0.6media 5 anni ≈1.0	≈1.0	·	·

Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y

Metrica	DERM	media 5 anni	Mediana dei peer	Verdetto
Revenue YoY (Ricavi YoY)	10.2%media 5 anni ≈9.4%	≈9.4%	·	·
Revenue CAGR 3Y (CAGR Ricavi 3Y)	-5.7%media 5 anni ≈3.9%	≈3.9%	·	·
Revenue CAGR 5Y (CAGR Ricavi 5Y)	6.8%	·	·	·

Metriche per Azione EPS, valore contabile per azione, flusso di cassa per azione, dividendo per azione

Metrica	DERM	media 5 anni	Mediana dei peer	Verdetto
EPS (Diluted) (EPS (Diluito))	$-0.47media 5 anni ≈$-1.48	≈$-1.48	·	·
Revenue / Share (Ricavi / Azione)	$2.52media 5 anni ≈$3.92	≈$3.92	·	·
Cash Flow / Share (Flusso di cassa / Azione)	$-0.51media 5 anni ≈$-0.49	≈$-0.49	·	·

Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti

Metrica	DERM	media 5 anni	Mediana dei peer	Verdetto
Asset Turnover (Rotazione delle attività)	0.7media 5 anni ≈0.8	≈0.8	0.4	Di prim'ordine
Inventory Turnover (Rotazione delle scorte)	1.7media 5 anni ≈2.8	≈2.8	0.8	Di prim'ordine
Receivables Turnover (Rotazione dei crediti)	3.1media 5 anni ≈3.3	≈3.3	6.1	Debole
Revenue / Employee (Ricavi / Dipendente)	≈$1.1M	·	·	·

valore · ≈ media 5 anni · mediana del settore · giudizio rispetto alla mediana

Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili

14

Sorpresa media 3.7%

Periodo	Rapporto	EPS Actual	EPS Stimato	Sorpresa
30 Giugno 2026	Ago 12, 2026	$-0.01	$-0.02	56.3%
31 Marzo 2026	Mag 13, 2026	$-0.08	$-0.08	-1.1%
31 Dicembre 2025		$-0.05	$-0.06	21.6%
30 Settembre 2025		$-0.09	$-0.05	-85.6%
30 Giugno 2025		$-0.16	$-0.11	-49.4%
31 Marzo 2025		$-0.18	$-0.24	25.7%
31 Dicembre 2024		$-0.15	$-0.36	58.3%

Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario

15

Conto Economico 16

Metrica	2025	2024	2023	2022	2021	2020
Revenue	$62M	$56M	$79M	$74M	$63M	$45M
Cost of Revenue	$21M	$21M	$23M	$31M	$32M	$15M
R&D Expense	$480.0K	$10M	$8M	$11M	$3M	·
SG&A Expense	$44M	$40M	$44M	$59M	$40M	$22M
Operating Expenses	$70M	$70M	$81M	$101M	$98M	$37M
Operating Income	$-8M	$-14M	$-2M	$-28M	$-35M	$8M
Interest Expense	·	·	$2M	$2M	$7M	$698.0K
Other Non-op	$-3M	$-934.0K	$-2M	$-2M	$-7M	$-698.0K
Pretax Income	$-11M	$-15M	$-4M	$-30M	$-42M	$7M
Income Tax	$60.0K	$61.0K	$221.0K	$63.0K	$2M	$2M
Net Income	$-11M	$-15M	$-4M	$-30M	$-44M	$5M
EPS (Basic)	$-0.47	$-0.72	$-0.21	$-1.69	$-4.32	$0.58
EPS (Diluted)	$-0.47	$-0.72	$-0.21	$-1.69	$-4.32	$0.49
Shares (Basic)	24,497,973	20,431,400	18,232,422	17,531,274	10,189,844	9,135,985
Shares (Diluted)	24,497,973	20,431,400	18,232,422	17,531,274	10,189,844	10,836,122
EBITDA	$-8M	$-14M	$-2M	$-28M	$-35M	·

Stato Patrimoniale 22

Metrica	2025	2024	2023	2022	2021	2020
Cash & Equivalents	$24M	$20M	$27M	$32M	$49M	$8M
Receivables	$30M	$10M	$15M	$28M	$23M	$24M
Inventory	$10M	$14M	$10M	$14M	$10M	$1M
Prepaid Expense	$3M	$3M	$4M	$3M	$2M	$2M
Current Assets	$67M	$48M	$56M	$78M	$84M	$35M
PP&E (Gross)	·	·	·	·	·	$11.0K
Accum. Depreciation	·	·	·	·	·	$11.0K
Intangibles	$28M	$32M	$20M	$27M	$13M	$15M
Other Non-current Assets	·	·	$6.0K	$95.0K	$150.0K	$6.0K
Total Assets	$95M	$80M	$77M	$105M	$97M	$52M
Accounts Payable	$9M	$16M	$18M	$37M	$23M	$2M
Accrued Liabilities	$28M	$17M	$20M	$19M	$23M	$21M
Current Liabilities	$37M	$35M	$42M	$67M	$52M	$28M
Capital Leases	$18.0K	$118.0K	$9.0K	$108.0K	·	$97.0K
Total Liabilities	$63M	$60M	$56M	$88M	$55M	$42M
Long-term Debt	$25M	$25M	$15M	$28M	·	·
Total Debt	$25M	$25M	$15M	$20M	·	·
Paid-in Capital	$130M	$107M	$93M	$85M	$81M	$5M
Retained Earnings	$-98M	$-87M	$-72M	$-69M	$-39M	$5M
Stockholders' Equity	$32M	$20M	$20M	$17M	$42M	$10M
Liabilities + Equity	$95M	$80M	$77M	$105M	$97M	$52M
Shares Outstanding	·	·	·	·	11,316,344	3,151,333

Flusso di cassa 15

Metrica	2025	2024	2023	2022	2021	2020
D&A	·	·	·	·	$0	$5.0K
Stock-based Comp	$6M	$6M	$3M	$4M	$2M	$153.0K
Deferred Tax	·	·	·	·	$2M	$-335.0K
Amort. of Intangibles	$4M	$3M	$4M	$4M	$2M	$1M
Other Non-cash	·	·	·	·	$38M	·
Operating Cash Flow	$-12M	$-9M	$5M	$-14M	$-2M	$5M
CapEx	·	$15M	$5M	$20M	·	·
Investing Cash Flow	·	$-15M	$-5M	$-20M	$-10M	$-1M
Stock Issued	$16M	$8M	$4M	·	$33M	·
Net Stock Activity	$16M	$8M	·	·	$33M	·
Financing Cash Flow	$16M	$17M	$-5M	$16M	$53M	$-487.0K
Net Change in Cash	$4M	$-7M	$-5M	$-17M	$41M	$3M
Taxes Paid	$50.0K	$125.0K	$181.0K	$168.0K	$158.0K	$110.0K
Free Cash Flow	·	$-24M	$240.0K	$-34M	·	·
Levered FCF	·	·	$-2M	$-36M	·	·

Redditività 7

Metrica	2025	2024	2023	2022	2021	2020
Operating Margin	-13.2%	-24.4%	-2.6%	-37.4%	-55.2%	·
Net Margin	-18.5%	-26.1%	-4.9%	-40.2%	-69.7%	·
Pretax Margin	-18.4%	-26.0%	-4.6%	-40.1%	-67.1%	·
EBITDA Margin	-13.2%	-24.4%	-2.6%	-37.4%	-55.2%	·
ROA	-13.1%	-18.7%	-4.2%	-29.3%	-59.0%	·
ROE	-44.7%	-94.7%	-20.4%	-137.3%	-290.1%	·
ROIC	-14.4%	-30.6%	-6.3%	-74.9%	-86.2%	·

Liquidità e Solvibilità 5

Metrica	2025	2024	2023	2022	2021	2020
Current Ratio	1.8	1.4	1.3	1.2	1.6	·
Quick Ratio	1.4	0.9	1.0	0.9	1.4	·
Debt / Equity	0.8	1.2	0.7	1.2	·	·
LT Debt / Equity	0.8	1.2	0.7	1.2	·	·
Interest Coverage	·	·	-1.2	-13.6	-5.0	·

Efficienza 3

Metrica	2025	2024	2023	2022	2021	2020
Asset Turnover	0.7	0.7	0.9	0.7	0.8	·
Inventory Turnover	1.7	1.7	2.2	2.6	5.7	·
Receivables Turnover	3.1	4.4	3.6	2.9	2.7	·

Per Azione 3

Metrica	2025	2024	2023	2022	2021	2020
Revenue / Share	$2.52	$2.75	·	$4.20	$6.20	·
Cash Flow / Share	$-0.51	$-0.45	·	$-0.77	$-0.21	·
EPS (TTM)	$-0.47	$-0.72	$-0.21	$-1.69	$-4.32	·

Tassi di Crescita 3

Metrica	2025	2024	2023	2022	2021	2020
Revenue YoY	10.2%	-29.1%	7.5%	16.7%	41.8%	·
Revenue CAGR 3Y	-5.7%	-3.8%	21.1%	·	·	·
Revenue CAGR 5Y	6.8%	·	·	·	·	·

Valutazione (TTM) 4

Metrica	2025	2024	2023	2022	2021	2020
Revenue TTM	$62M	$56M	$79M	$74M	$63M	·
Net Income TTM	$-11M	$-15M	$-4M	$-30M	$-44M	·
P/E	-16.4	-5.4	-27.4	-1.1	-1.2	·
Earnings Yield	-6.1%	-18.4%	-3.6%	-88.0%	-80.3%	·

Conto Economico 16

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue	$19M	$16M	$16M	$18M	$15M	$13M	$14M	$15M	$15M	$13M	$15M	$35M	$17M	$12M	$16M	$16M
Cost of Revenue	$6M	$6M	·	·	$5M	$5M	$2M	$5M	$7M	$7M	$2M	$6M	$8M	$6M	$8M	$7M
R&D Expense	$54.0K	·	$154.0K	$287.0K	$0	$39.0K	$218.0K	$842.0K	$913.0K	$8M	$2M	$2M	$2M	$2M	$4M	$3M
SG&A Expense	$11M	$10M	$10M	$12M	$12M	$11M	$10M	$11M	$10M	$8M	$10M	$9M	$12M	$13M	$14M	$16M
Operating Expenses	$18M	$17M	$17M	$19M	$18M	$16M	$11M	$18M	$18M	$23M	$17M	$17M	$25M	$22M	$26M	$26M
Operating Income	$456.0K	$-1M	$-443.0K	$-2M	$-3M	$-3M	$2M	$-3M	$-3M	$-10M	$-2M	$17M	$-8M	$-10M	$-10M	$-9M
Interest Expense	·	·	·	·	·	·	·	·	·	$548.0K	·	$268.0K	$756.0K	$650.0K	$617.0K	$559.0K
Other Non-op	$-753.0K	$-738.0K	$-804.0K	$-786.0K	$-860.0K	$-749.0K	$-652.0K	$504.0K	$-434.0K	$-352.0K	$87.0K	$-361.0K	$-710.0K	$-575.0K	$-634.0K	$-578.0K
Pretax Income	$-297.0K	$-2M	$-1M	$-2M	$-4M	$-4M	$2M	$-2M	$-3M	$-10M	$-2M	$17M	$-8M	$-10M	$-11M	$-10M
Income Tax	$15.0K	·	$0	$0	$60.0K	·	·	·	·	·	$126.0K	$95.0K	·	·	$13.0K	$10.0K
Net Income	$-312.0K	$-2M	$-1M	$-2M	$-4M	$-4M	$2M	$-2M	$-3M	$-10M	$-2M	$17M	$-8M	$-10M	$-11M	$-10M
EPS (Basic)	$-0.01	$-0.08	$-0.04	$-0.09	$-0.16	$-0.18	$0.10	$-0.12	$-0.17	$-0.53	$-0.09	$0.91	$-0.46	$-0.57	$-0.61	$-0.57
EPS (Diluted)	$-0.01	$-0.08	$-0.04	$-0.09	$-0.16	$-0.18	$0.10	$-0.12	$-0.17	$-0.53	$0.02	$0.80	$-0.46	$-0.57	$-0.61	$-0.57
Shares (Basic)	27,493,693	27,305,028	·	24,959,114	23,290,806	22,611,040	·	20,537,794	19,993,858	19,757,449	·	18,416,368	18,005,055	17,807,194	·	17,618,064
Shares (Diluted)	27,493,693	27,305,028	·	24,959,114	23,290,806	22,611,040	·	20,537,794	19,993,858	19,757,449	·	21,034,758	18,005,055	17,807,194	·	17,618,064
EBITDA	$456.0K	$-1M	·	$-2M	$-3M	$-3M	·	$-3M	$-3M	$-10M	·	$17M	$-8M	$-10M	·	$-9M

Stato Patrimoniale 20

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Cash & Equivalents	$26M	$27M	$24M	$25M	$20M	$21M	$20M	$22M	$24M	$24M	$27M	$25M	$8M	$17M	$32M	$35M
Receivables	$36M	$25M	$30M	$18M	$16M	$18M	$10M	$11M	$10M	$10M	$15M	$8M	$17M	$28M	$28M	$29M
Inventory	$8M	$9M	$10M	$12M	$13M	$12M	$14M	$12M	$10M	$11M	$10M	$11M	$12M	$13M	$14M	$15M
Prepaid Expense	$3M	$3M	$3M	$2M	$2M	$2M	$3M	$1M	$2M	$3M	$4M	$924.0K	$2M	$2M	$3M	$942.0K
Current Assets	$73M	$65M	$67M	$56M	$51M	$54M	$48M	$46M	$46M	$47M	$56M	$45M	$48M	$61M	$78M	$80M
Intangibles	$26M	$26M	$28M	$29M	$30M	$31M	$32M	$18M	$19M	$19M	$20M	$21M	$22M	$26M	$27M	$28M
Other Non-current Assets	·	·	·	·	·	·	·	$6.0K	$6.0K	$6.0K	$6.0K	$6.0K	$6.0K	$88.0K	$95.0K	$103.0K
Total Assets	$98M	$92M	$95M	$85M	$81M	$85M	$80M	$64M	$65M	$67M	$77M	$66M	$70M	$96M	$105M	$108M
Accounts Payable	$8M	$8M	$9M	$12M	$13M	$14M	$16M	$15M	$15M	$15M	$18M	$28M	$32M	$44M	$37M	$34M
Accrued Liabilities	$32M	$26M	$28M	$21M	$23M	$23M	$17M	$16M	$16M	$20M	$20M	$16M	$23M	$17M	$19M	$18M
Short-term Debt	·	·	·	·	·	·	·	·	·	·	·	·	·	·	·	$0
Current Liabilities	$46M	$38M	$37M	$40M	$40M	$40M	$35M	$33M	$34M	$39M	$42M	$49M	$68M	$77M	$67M	$61M
Capital Leases	·	·	$18.0K	$44.0K	$69.0K	$94.0K	$118.0K	·	·	·	$9.0K	$34.0K	$59.0K	$84.0K	$108.0K	·
Total Liabilities	$66M	$61M	$63M	$59M	$62M	$63M	$60M	$53M	$54M	$54M	$56M	$49M	$70M	$88M	$88M	$82M
Long-term Debt	$25M	$25M	$25M	$25M	$25M	$25M	$25M	$20M	$20M	$15M	$15M	$0	$10M	$23M	$28M	·
Total Debt	$25M	$25M	·	$25M	$25M	$25M	·	$20M	$20M	$15M	·	·	$10M	$20M	·	$20M
Paid-in Capital	$133M	$132M	$130M	$123M	$114M	$113M	$107M	$99M	$97M	$96M	$93M	$88M	$87M	$86M	$85M	$84M
Retained Earnings	$-101M	$-101M	$-98M	$-97M	$-95M	$-91M	$-87M	$-89M	$-86M	$-83M	$-72M	$-70M	$-87M	$-79M	$-69M	$-58M
Stockholders' Equity	$32M	$31M	$32M	$26M	$19M	$22M	$20M	$11M	$11M	$13M	$20M	$17M	$5.0K	$7M	$17M	$26M
Liabilities + Equity	$98M	$92M	$95M	$85M	$81M	$85M	$80M	$64M	$65M	$67M	$77M	$66M	$70M	$96M	$105M	$108M

Flusso di cassa 11

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Stock-based Comp	$1M	$989.0K	$2M	$2M	$1M	$1M	$1M	$2M	$2M	$1M	$529.0K	$558.0K	$873.0K	$646.0K	$1M	$1M
Amort. of Intangibles	$969.0K	$1M	$1M	$1M	$1M	$1M	$982.0K	$814.0K	$814.0K	$814.0K	$815.0K	$814.0K	$1M	$1M	$1M	$1M
Operating Cash Flow	$-2M	$3M	$-6M	$-2M	$-942.0K	$-3M	$2M	$-1M	$-5M	$-5M	$-17M	$19M	$4M	$-956.0K	$-4M	$-7M
CapEx	·	·	·	·	·	·	·	·	·	·	$0	$0	$0	$5M	$0	$0
Investing Cash Flow	·	·	·	·	·	·	·	·	·	·	$0	$0	$0	$-5M	$0	$0
Stock Issued	·	·	$5M	$7M	$0	$4M	$6M	$194.0K	$0	$1M	·	·	·	·	·	·
Net Stock Activity	·	·	·	·	·	$4M	·	·	·	$1M	·	·	·	·	·	·
Financing Cash Flow	$158.0K	$220.0K	$5M	$7M	$165.0K	$4M	$11M	$-294.0K	$5M	$2M	$19M	$-11M	$-13M	$52.0K	$948.0K	$4M
Net Change in Cash	$-2M	$3M	$-858.0K	$5M	$-777.0K	$765.0K	$-2M	$-1M	$-145.0K	$-3M	$3M	$8M	$-9M	$-6M	$-3M	$-3M
Taxes Paid	·	·	$1.0K	$0	·	·	$21.0K	$1.0K	·	·	$96.0K	$0	$78.0K	$7.0K	$149.0K	·
Free Cash Flow	·	·	·	·	·	·	·	·	·	·	·	·	·	$-6M	·	·

Redditività 7

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Operating Margin	2.5%	-9.3%	·	-8.7%	-19.2%	-25.3%	·	-19.8%	-19.7%	-77.4%	·	49.9%	-44.6%	-78.3%	·	-58.9%
Net Margin	-1.7%	-14.0%	·	-13.1%	-25.3%	-31.0%	·	-16.3%	-22.6%	-80.1%	·	48.6%	-48.7%	-83.0%	·	-62.5%
Pretax Margin	-1.6%	-14.0%	·	-13.1%	-24.9%	-31.0%	·	-16.3%	-22.6%	-80.1%	·	48.9%	-48.7%	-83.0%	·	-62.5%
EBITDA Margin	2.5%	-9.3%	·	-8.7%	-19.2%	-25.3%	·	-19.8%	-19.7%	-77.4%	·	49.9%	-44.6%	-78.3%	·	-58.9%
ROA	-0.35%	-2.5%	·	-3.1%	-5.2%	-5.4%	·	-3.7%	-5.0%	-12.9%	·	19.3%	-9.1%	-9.3%	·	-10.2%
ROE	-1.2%	-8.5%	·	-12.6%	-24.9%	-23.6%	·	-16.9%	-59.5%	-102.2%	·	77.1%	-48.1%	-41.4%	·	-139.3%
ROIC	0.83%	·	·	·	-6.6%	·	·	·	·	·	·	98.7%	·	·	·	-20.7%

Liquidità e Solvibilità 5

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Current Ratio	1.6	1.7	·	1.4	1.3	1.3	·	1.4	1.4	1.2	·	0.9	0.7	0.8	·	1.3
Quick Ratio	1.4	1.4	·	1.1	0.9	1.0	·	1.0	1.0	0.9	·	0.7	0.4	0.6	·	1.0
Debt / Equity	0.8	0.8	·	1.0	1.3	1.2	·	1.8	1.7	1.1	·	·	1988.4	2.6	·	0.8
LT Debt / Equity	0.6	0.7	·	0.8	1.1	1.1	·	1.8	1.7	1.1	·	·	·	1.3	·	0.8
Interest Coverage	·	·	·	·	·	·	·	·	·	-18.4	·	64.3	-10.1	-14.7	·	-17.0

Efficienza 3

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Asset Turnover	0.2	0.2	·	0.2	0.2	0.2	·	0.2	0.2	0.2	·	0.4	0.2	0.1	·	0.2
Inventory Turnover	0.6	0.6	·	·	·	·	·	0.5	0.6	0.6	·	0.5	0.6	0.4	·	0.5
Receivables Turnover	0.7	0.7	·	1.2	1.1	0.9	·	1.6	1.1	0.7	·	1.9	0.8	0.4	·	0.5

Per Azione 3

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue / Share	$0.67	$0.58	·	$0.71	$0.64	$0.58	·	$0.71	$0.74	$0.66	·	$1.64	$0.95	$0.69	·	$0.91
Cash Flow / Share	·	$0.11	·	·	·	$-0.13	·	·	·	$-0.25	·	·	·	$-0.05	·	·
EPS (TTM)	$-0.22	$-0.37	·	$-0.33	$-0.36	$-0.37	·	$-0.80	$0.12	$-0.17	·	$-0.84	$-2.21	$-2.18	·	$-2.96

Valutazione (TTM) 4

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue TTM	$68M	$65M	·	$59M	$56M	$56M	·	$58M	$78M	$80M	·	$80M	$61M	$63M	·	$75M
Net Income TTM	$-6M	$-10M	·	$-9M	$-9M	$-8M	·	$-18M	$843.0K	$-4M	·	$-12M	$-39M	$-38M	·	$-41M
P/E	-32.2	-12.7	·	-21.6	-19.9	-15.9	·	-7.1	47.0	-21.6	·	-3.3	-0.7	-0.7	·	-0.8
Earnings Yield	-3.1%	-7.9%	·	-4.6%	-5.0%	-6.3%	·	-14.2%	2.1%	-4.6%	·	-30.7%	-139.0%	-138.8%	·	-120.3%

Periodo più recente a sinistra · valori nulli mostrati come ·

Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni

16

Metrica	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Ricavi	$62M	$56M	$79M	$74M	$63M
Margine Operativo %	-13.2%	-24.4%	-2.6%	-37.4%	-55.2%
Utile netto	$-11M	$-15M	$-4M	$-30M	$-44M
EPS Diluito	$-0.47	$-0.72	$-0.21	$-1.69	$-4.32

Metrica	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Debito / Patrimonio Netto	0.8	1.2	0.7	1.2	·
Rapporto corrente	1.8	1.4	1.3	1.2	1.6
Quick Ratio	1.4	0.9	1.0	0.9	1.4

Metrica	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Flusso di cassa libero	·	$-24M	$240.0K	$-34M	·

Proprietari istituzionali (13F) 75 filer · $72.0M totale · Aggiornato al 30 Giugno 2026

17

Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.

Detentori 75

Valore detenuto $72.0M

Nuove posizioni 25

Posizioni chiuse 23

Attività istituzionale — Q2 2026 vs trimestre precedente

Nuove posizioni	Posizioni chiuse	Aumentato	Diminuito	Variazione netta delle azioni
25 (+10 vs trimestre precedente)	23 (+8 vs trimestre precedente)	17 (-14 vs trimestre precedente)	23 (+6 vs trimestre precedente)	-4.1M

Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.

Istituzione	Valore	Azioni	% di 13F tracciati	Tipo
TANG CAPITAL MANAGEMENT LLC	$11.398.800	1.610.000	15,83%	Azioni
WASATCH ADVISORS LP	$10.005.505	2.133.370	13,90%	Azioni
VANGUARD GROUP INC	$5.891.574	764.147	8,18%	Azioni
VANGUARD CAPITAL MANAGEMENT LLC	$4.780.310	675.185	6,64%	Azioni
PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC.	$3.794.880	536.000	5,27%	Azioni
Pale Fire Capital SE	$3.742.375	528.584	5,20%	Azioni
Opaleye Management Inc.	$2.478.000	350.000	3,44%	Azioni
Summit Financial, LLC	$2.454.976	346.748	3,41%	Azioni
JANE STREET GROUP, LLC	$2.265.749	320.021	3,15%	Azioni
Diametric Capital, LP	$2.093.294	295.663	2,91%	Azioni
Ikarian Capital, LLC	$1.780.168	251.436	2,47%	Azioni
RENAISSANCE TECHNOLOGIES LLC	$1.626.276	229.700	2,26%	Azioni
GEODE CAPITAL MANAGEMENT, LLC	$1.530.115	216.004	2,13%	Azioni
AMERICAN FINANCIAL GROUP INC	$1.274.400	180.000	1,77%	Azioni
Trexquant Investment LP	$1.213.073	171.338	1,69%	Azioni
MARSHALL WACE, LLP	$990.087	139.843	1,38%	Azioni
J. Goldman & Co LP	$974.095	137.584	1,35%	Azioni
Sheets Smith Investment Management	$946.276	132.904	1,31%	Azioni
MILLENNIUM MANAGEMENT LLC	$778.913	110.016	1,08%	Azioni
BlackRock, Inc.	$714.945	100.981	0,99%	Azioni
XTX Topco Ltd	$714.535	100.923	0,99%	Azioni
VANGUARD FIDUCIARY TRUST CO	$670.681	94.729	0,93%	Azioni
GOLDMAN SACHS GROUP INC	$639.282	90.294	0,89%	Azioni
UBS Group AG	$591.279	83.514	0,82%	Azioni
CITADEL ADVISORS LLC	$581.615	82.149	0,81%	Azioni
PVG ASSET MANAGEMENT CORP	$563.377	79.573	0,78%	Azioni
BOOTHBAY FUND MANAGEMENT, LLC	$477.489	67.442	0,66%	Azioni
STATE STREET CORP	$467.124	65.978	0,65%	Azioni
ENVESTNET ASSET MANAGEMENT INC	$466.041	65.825	0,65%	Azioni
Walleye Capital LLC	$463.471	65.462	0,64%	Azioni
Geneos Wealth Management Inc.	$448.022	63.280	0,62%	Azioni
Frec Markets, Inc.	$357.540	50.500	0,50%	Azioni
BNP PARIBAS FINANCIAL MARKETS	$335.670	47.411	0,47%	Azioni
Squarepoint Ops LLC	$321.467	45.405	0,45%	Azioni
MORGAN STANLEY	$297.530	42.024	0,41%	Azioni
BANK OF AMERICA CORP /DE/	$296.701	41.907	0,41%	Azioni
Integrated Wealth Concepts LLC	$280.212	39.578	0,39%	Azioni
ADAR1 Capital Management, LLC	$279.780	39.517	0,39%	Azioni
STATE OF WISCONSIN INVESTMENT BOARD	$254.200	35.904	0,35%	Azioni
NORTHERN TRUST CORP	$252.444	35.656	0,35%	Azioni
Aster Capital Management (DIFC) Ltd	$217.498	30.720	0,30%	Azioni
SALEM INVESTMENT COUNSELORS INC	$206.736	29.200	0,29%	Azioni
Quadrature Capital Ltd	$204.194	28.841	0,28%	Azioni
JANE STREET GROUP, LLC	$201.072	28.400	0,28%	Opzione Call
AQR CAPITAL MANAGEMENT LLC	$176.129	24.877	0,24%	Azioni
PRELUDE CAPITAL MANAGEMENT, LLC	$155.087	21.905	0,22%	Azioni
SUSQUEHANNA INTERNATIONAL GROUP, LLP	$141.607	20.001	0,20%	Azioni
Gladstone Institutional Advisory LLC	$141.600	20.000	0,20%	Azioni
Brevan Howard Capital Management LP	$133.508	18.857	0,19%	Azioni
Invesco Ltd.	$118.087	16.679	0,16%	Azioni

Mostra tutti i 75 proprietari istituzionali →

Insider aziendali 11 insider · 4 dirigenti · 7 direttori

19

Insider	Ruolo	Ultima attività	Azioni possedute	Netto 12m
Claude Maraoui	President & CEO	22 Aprile 2026 A	2.435.990	$0
Joseph Benesch	CFO	22 Aprile 2026 A	261.371	$0
Ernest Robert De Paolantonio	As of the date of the original Form 4 filed on October 6, 2022, the Reporting Person was the Chief Financial Officer of the Issu	04 Ottobre 2022 S	259.907	$0
Ramsey Alloush	Chief Operating Officer	22 Aprile 2026 A	598.543	$0
Justin Adam Smith	Direttore	01 Luglio 2026 A	231.618	$0
Miranda Jayne Toledano	Direttore	01 Luglio 2026 A	168.618	$0
Neil Herskowitz	Direttore	01 Luglio 2026 A	168.618	$0
Michael Cooper Pearce	Direttore	25 Giugno 2026 A	67.173	$0
Lindsay A. Rosenwald, M.D.	Direttore	25 Giugno 2026 A	221.146	$0
Jeffrey Paley	Direttore	08 Novembre 2023 S	114.217	$0
Fortress Biotech, Inc.	Proprietario del 10%	12 Maggio 2023 J	3.860.467	$0

Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato

Proprietà ETF Posseduti da 4 ETF

20

Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.

Fondo	Peso	Unità	Aggiornato al	Fonte
QQQS · Invesco Exchange-Traded Fund Trust …	0,47%	16.187 SH	02 Ottobre 2026	Giornaliero
IWC · iShares Trust	0,03%	50.596 SH	11 Settembre 2026	Giornaliero
VXF · VANGUARD INDEX FUNDS	0,00%	186.966 SH	19 Agosto 2026	Giornaliero
VTI · VANGUARD INDEX FUNDS	0,00%	470.426 SH	19 Agosto 2026	Giornaliero

DERM Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo

21

rating · 10 analisti COMPRA

Target mediano $13.50 +104,2%

2 20,0% Acquisto forte

7 70,0% Compra

1 10,0% Mantieni

0 0,0% Vendi

0 0,0% Vendita forte

Target Price a 12 Mesi

4 analisti · 2026-09-29

Target medio $13.75 +108,0%

← Sotto tutti i target Prezzo attuale $6.61

Basso$13.00 Media$13.75 Alto$15.00

Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore

22

Base FY, prezzi alla chiusura dell'ultimo anno fiscale di ciascuna società.

Ticker	Capitalizzazione di Mercato	P/E	Rev YoY	Margine Netto	ROE	Margine lordo
DERM	·	-16.4	10.2%	-18.5%	-44.7%	·
SIGA	$438M	19.1	-31.8%	24.6%	11.4%	·
ANTX	$31M	-1.0	·	·	-57.7%	·
ORMP	$112M	1.9	-50.4%	3202.5%	37.0%	0.65%
NRXP	·	·	·	·	·	·
LLY	·	46.8	44.7%	31.7%	101.2%	·

Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi

26

Scegli le metriche che contano per te: fai clic sul + accanto a qualsiasi riga in Fondamentali Completi sopra.

La tua selezione è salvata e ti segue su tutti i ticker.

DERM Journey Medical Corporation - Common Stock